Pfizer is down about 5% in the past week and still well below where it was a year ago. The patent cliff is the real problem. Dr-gs that brought in billions are losing exclusivity, and that is a huge hole to fill. They keep cutting jobs to save money, but the pipeline does not have a clear winner yet. The weight loss dr-g everyone talks about will not launch until 2028 at the earliest. In the meantime, anything can go wrong. Is the wait really worth it?
There are no replies in this thread yet. Be the first to post a reply below: